Maven Securities »

Catalyst Pharmaceutical Partners shares owned by Maven Securities

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Maven Securities

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.9M 124k 31.43

More positions owned by Maven Securities

Vaneck Etf Trust Call Call Option
Ishares Tr Call Call Option
Vaneck Etf Trust Put Put Option
State Str Spdr S&p 500 Et F T Put
Microsoft Corp Put Put Option
Invesco Qqq Tr Put Put Option
Micron Technology Call Call Option
Select Sector Spdr Tr Put Put Option
Meta Platforms Put Put Option
Microsoft Corporation (MSFT)
Unitedhealth Group Put Put Option
Select Sector Spdr Tr Call Call Option
Nvidia Corporation Put Put Option
Advanced Micro Devices In C Call
Ishares Tr Put Put Option

View all positions for Maven Securities

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Glazer Capital
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners